Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

Clinical trial NCT00170781 · COMPLETED

Trial details

NCT number: NCT00170781
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Gouty Arthritis

Start date: 2005-06-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.